✦ LIBER ✦

Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease

✍ Scribed by Kurth, Matthias C. ;Kurth, Janice H.

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 308 KB
Volume: 48
Category: Article
ISSN: 0148-7299
DOI: 10.1002/ajmg.1320480311

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acetaminophen metabolism by cytochrome P

Acetaminophen metabolism by cytochrome P450 monooxygenases in Parkinson's disease

✍ Stewart A. Factor; William J. Weiner; Franz Hefti 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB

Effects of psychopharmacotherapy on phen

Effects of psychopharmacotherapy on phenotypic expression of cytochrome P450 2D6 in patients genotyped for CYP2D6 mutations

✍ O Zelenková; E Hadasová; E Česková; M Vojtísková; M Hyksová 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

No Abstract

The CYP2D6B mutant allele is overreprese

The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease

✍ Dr. T. Saitoh; Y. Xia; X. Chen; E. Masliah; D. Galasko; C. Shults; L. J. Thal; L 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB 👁 1 views

Absence of effect of seven functional mu

Absence of effect of seven functional mutations in the cyp2d6 gene in Parkinson's disease

✍ Oscar Joost; Catherine A. Taylor; Catherine A. Thomas; L. Adrienne Cupples; Mari 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

Validation of higher-throughput high-per

Validation of higher-throughput high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry assays to conduct cytochrome P450s CYP2D6 and CYP3A4 enzyme inhibition studies in human liver microsomes

✍ Inhou Chu; Leonard Favreau; Tony Soares; Chin-chung Lin; Amin A. Nomeir 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 2 views

In the early stage of drug discovery, thousands of new chemical entities (NCEs) may be screened before a single drug candidate can be identified for development. In order to accelerate the drug discovery process, we have developed higher-throughput enzyme assays to evaluate the inhibition of cytochr